HealthFlex
×
  • Home
  • Conference
    • Scientific Program
    • Speakers
    • Posters
    • Registration
    • Abstract Submission
  • Location & Travel
    • The Venue
    • Accommodation
    • Vienna Travel Guide
  • Sponsors
  • Contact
  • Register
Katia Duquesne

Katia Duquesne

AMU – CNRS – Marseille, France

The terpene mini-path (TMP): a new artificial terpene biosynthetic pathway

Terpenes are the largest class of natural products with more than 100,000 different structures described to date. Due to the diversity of their biological and physicochemical properties, terpenes are the preferred targets of many industries. However, due to their rarity and/or their low concentration in living organisms, access to these molecules is problematic in relation to the protection of living species and the environment. On the other hand, due to their structural complexity, the chemical synthesis of these molecules is hardly possible industrially.
We have developed a two-enzymes synthetic cascade (TMP) to generate the universal precursors of all terpenes (DMAPP: dimethylallyl diphosphate and IPP: isopentenyl diphosphate) in only 2 steps (instead of 18 for a natural access) from their corresponding alcohols. Then, these precursors are the building blocks for all terpene production by adding to TMP a prenyl transferase and the enzyme allowing cyclization.
We were able to apply this enzymatic cascade to the in vivo and in vitro synthesis of a cytotoxic prenyl derivative of brevianamide F, tryprostatin B; to the in vitro synthesis of farnesyl diphosphate (FPP), the precursor of all sesquiterpenes and triterpenes; and to the in vivo synthesis of, for example, delta-cadinol, a sesquiterpene of interest. On the other hand, the structure of the terpene mini-path also allows a simplified access to non-natural terpenes. We were thus able to synthesize the cyclobutyl derivatives of both FPP and tryprostatin B. These results allow to envisage the industrial implementation of a new and very general way of producing terpenes, either in vitro or in vivo; but also to explore the biodiversity and characterize new terpene synthases.

_________

X. Ma, H. Liang, Q.Pan, K.L.J. Prather, A.J. Sinskey, G. Stephanopoulos, and K. Zhou. J. Agric. Food Chem. 2022, 70, 3512−3520.
J. Bohlmann, Cl. Keeling. Plant J. 2008, 54(4):656-69.
K. Paramasivan, S. Mutturi. Pr. Crit. Rev. Biotechnol. 2017, 37(8):974-989.
J. Couillaud, J. Rico, A. Rubini, T. Hamrouni, E. Courvoisier-Dezord, J.L.Petit, A. Mariage, E. Darii, K. Duquesne, V. de Berardinis and G. Iacazio. ACS Omega. 2019, 4(4), 7838–7849.
M. Ringel, N. Dimos, S. Himpich, M. Haack, C. Huber, W. Eisenreich, G. Schenk, B. Loll and T. Brück. Microbial Cell Factories. 2022, 21 (1):64.

__________

View Abstract as PDF:

OP17_Katia Duquesne.pdf

_________

Wed. April 17 | 11:20 – 10:50 hrs – The terpene mini-path (TMP): a new artificial terpene biosynthetic pathway

6th Multistep Enzyme Catalyzed Processes -MECP 2024 will be
held in Vienna from April 14 till April 17 in 2024.

+43664 60588 7146

admin@mecp2024.com

https://mecp2024.com

Getreidemarkt 9/163, 1060 Vienna, Austria.

Quick Links

  • Home
  • Conference
    • Scientific Program
    • Speakers
    • Posters
    • Registration
    • Abstract Submission
  • Location & Travel
    • The Venue
    • Accommodation
    • Vienna Travel Guide
  • Sponsors
  • Contact
  • Register

Latest News

Copyright ©2025 | Billigtech e.U.
Imprint | Privacy Policy |